Meeting Coverage

ACTRIMS

Americas Committee on Treatment and Research in Multiple Sclerosis

MS Patients on Cladribine Show Fewer Relapses

Real-world data analysis compares oral disease-modifying therapies

ACTRIMS over a photo of Palm Beach County Convention Center

Latest ACTRIMS Meetings

Stem Cell Transplantation Shows Benefits in Aggressive MS

No new relapses recorded after autologous transplant

February 28, 2022
Deep Learning Identifies PPMS Patients Who May Respond to Treatment

Predictive enrichment could increase the power of future trials

February 27, 2022
Paramagnetic Rim Lesions Highly Specific in MS Diagnosis

Sensitivity, accuracy also high in prospective study

February 26, 2022
Cervical Cord Atrophy Predicts Silent MS Progression

Ventricular enlargement was second strongest indicator

February 26, 2022
COVID Vax Response Still Impaired in Some MS Patients After Third Shot

Subset of multiple sclerosis patients seroconverted after third dose, however

February 25, 2022
Real-World Study Shows MS Patients Have High Infection Risks

Urinary, kidney infections especially are more common for people with MS than others

March 2, 2021
Juggling COVID Vax, MS Therapies Proves Challenging

The issue: some multiple sclerosis drugs may attenuate antibody responses to vaccination

March 1, 2021
Worse COVID-19 Outcomes Tied to MS Disability, Age

North American data echoes findings from around the world

February 28, 2021
Multiple Sclerosis and Depression: Are Links Causal?

Mendelian randomization study says no, but predisposition to obesity may play a role

February 28, 2021
Blood Biomarker Linked with MS Disability, Brain Atrophy

Diabetes, smoking, BMI may influence serum NfL, real-world study suggests

February 27, 2021
Telemedicine Gets Thumbs Up, MS Specialists Say

Most providers want to keep using it, but limitations need to be resolved

February 27, 2021
Can MS Treatment Be Stopped?

Pendulum keeps swinging on risks from drug discontinuation

March 4, 2019